News | February 18, 2008

Report Finds Med Tech Price Disclosure Would Likely Increase Prices

February 19, 2008 - A new study released today found pending congressional legislation seeking the mandatory disclosure of prices for certain medical technologies might result in increased prices and no tangible benefits to patients.

The study, released today at the National Press Club by its authors Robert W. Hahn, executive director, Reg-Markets Center and senior fellow at the American Enterprise Institute, and Hal J. Singer, president of Criterion Economics, examines the potential economic impact of the Transparency in Medical Device Pricing Act of 2007 (S. 2221), recently introduced in the U.S. Senate.

In the report, the researchers review previous attempts by governments to impose price disclosure rules in a number of other industries including cell phones, groceries, cement, barges, railroads and long-distance telephone services. The authors use evidence from case studies and other sources to identify four conditions that, if satisfied, imply that mandatory price disclosure would provide large benefits to consumers or other purchasers.

“We found that mandatory price disclosure, as proposed in S.2221 is unlikely to benefit patients or hospitals and worse, will likely increase costs,” Hahn said.

The authors write that in order for price disclosure to have a favorable effect, there must be large search costs that are reduced substantially, and that the pricing information disclosed be current. The industry-specific market conditions essential for lower prices to occur would require that any savings be passed on to end users, and that there is a large variation in the price paid by purchasers and consumers.

Specifically, the report found the medical device industry is concentrated among a few firms and competitors repeatedly interact in the marketplace. There are few, if any, economical substitutes for many medical devices. Some medical devices are standardized, whereas other devices are differentiated. The report also found that most of the firms do not already know their rivals’ prices.

The report conclude that significant search costs for hospitals and patients would remain and disclosure would not provide current price information, since the data would be at least three months old. The report also concluded the structure of the healthcare industry would not ensure that hospitals pass cost savings on to consumers.

“Applying these conditions to the medical device industry, we conclude that mandatory price disclosure policy would likely increase prices hospitals pay for these products and provide no tangible benefit to patients,” the authors said.

The study was supported by the Advanced Medical Technology Association.

For more information: www.criterioneconomics.com

Related Content

Philips Introduces Technology Maximizer Program for Imaging Equipment Upgrades
Technology | Imaging | January 17, 2018
January 17, 2018 — Philips recently announced the launch of Technology Maximizer, a cross-modality program designed t
Videos | RSNA 2017 | December 20, 2017
ITN and DAIC Editor Dave Fornell takes a tour of some of the most interesting new medical imaging technologies on the
Philips Azurion Platform Improves Clinical Workflow and Staff Experience Benefits
News | Angiography | December 04, 2017
Philips recently announced the results of a comprehensive, independent, two-year study demonstrating the clinical...
Philips Azurion Image-Guided Therapy Platform Improves Clinical Workflow for Interventional Procedures
News | Angiography | November 15, 2017
Philips announced the results of a comprehensive, independent, two-year study demonstrating the clinical workflow...
Siemens Healthineers Introduces Share360 Tailored Service Portfolio
News | Imaging | November 10, 2017
November 10, 2017 — To address the specific needs of...
GE Healthcare and Medis Collaborate to Expand Availability of Quantitative Flow Ratio Software
News | Angiography | November 10, 2017
GE Healthcare and Dutch-based cardiovascular imaging software provider Medis announced at the 2017 Transcatheter...
UnityPoint Health Installs Infinix-i 4-D CT System for Interventional Procedures
News | Interventional Radiology | November 08, 2017
November 8, 2017 — Physicians at UnityPoint Health Methodist, Peoria, Ill., are now offering fast, safe and accurate
Ziehm Imaging Named Mobile Interventional X-ray Company of the Year by Frost & Sullivan
News | Mobile C-Arms | November 02, 2017
November 2, 2017 — Based on its recent analysis of the mobile interventional X-ray solutions market, Frost & Sull
Ziehm Vision FD Earns Best New Product of the Year at Stevie Awards
News | Mobile C-Arms | October 26, 2017
October 26, 2017 — Ziehm Vision FD has been recognized with the Silver Stevie Award as "Best new product of the year"
Toshiba Highlights Interventional Imaging at RSNA 2017
News | Interventional Radiology | September 27, 2017
Toshiba Medical announced it will highlight several of its latest vascular and interventional imaging solutions at the...
Overlay Init